icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Ledipasvir/Sofosbuvir With Ribavirin is Safe and Efficacious in Decompensated and Post-Liver Transplantation Patients With HCV Infection: Preliminary Results of the SOLAR-2 Trial
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Michael Manns1, Xavier Forns2, Didier Samuel3, Jill Denning4, Sarah Arterburn4, Theo Brandt-Sarif4, Hadas Dvory-Sobol4, Phillip S. Pang4, John G. McHutchison4, Edward Gane5, David Mutimer6
1Hannover Medical School, Hannover, Germany; 2Liver Unit, IDIBAPS, CIBEREHD Hospital Clinic, Barcelona, Spain; 3Université Paris-Sud, Villejuif, France; 4Gilead Sciences, Foster City, California, USA; 5University of Auckland, Auckland, New Zealand; 6Queen Elizabeth Hospital and University of Birmingham, Birmingham, England

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif

EASL12.gif

EASL13.gif

EASL14.gif

EASL15.gif

EASL16.gif

EASL17.gif

EASL18.gif

EASL19.gif